• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

News & Events

  • Print
  • Share
  • E-mail

Public Calendar: February 1-5, 2010

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.

February 1-5, 2010

FDA Official and Title

Date

Location

Other FDA Participants

Non-FDA Participants

Subject

Margaret A. Hamburg, M.D., Commissioner of Food and Drugs2/2/10Washington, DCAntonio Mattia, John Leighton, Marc Walton, Stefano Luccioli, Steven GendelDavid Longfellow (Toxicology Forum)Speech at 35th Annual Toxicology Forum
Margaret A. Hamburg, M.D., Commissioner of Food and Drugs2/3/10Washington, DCN/AAndrew von Eschenbach (Center for Health Transformation)New role at Center for Health Transformation
Margaret A. Hamburg, M.D., Commissioner of Food and Drugs2/4/10Washington, DCMolly Muldoon, Meghan ScottJ. Stephen Morrison, Reuben Jeffery III (Center for Strategic and International Studies); Thomas Bollyky (Center for Global Development); Henry Chin (Coca-Cola Company)Speech at The Center for Strategic and International Studies
Joshua M. Sharfstein, M.D., Principal Deputy Commissioner of Food and Drugs2/2/10Silver Spring, MDAnn Witt, Helen WinkleRoger Williams, Susan de Mars, Matthew Heyman, Ben Firschein (U.S. Pharmacopeia)Collaboration with FDA
Jesse Goodman, M.D., M.P.H., Chief Scientist and Deputy Commissioner for Science and Public Health2/2/10Silver Spring, MDLuciana Borio, Brad LeissaPeter Mueller, Mark Namchuk,  Ann Kwong, Paul Charifson, Jack Weet, Ladd Wiley (Vertex Pharmaceuticals); Akin Gump (Consultant)Influenza-A Research Program
Russell Abbott, Deputy Commissioner for Administration2/1/10-
2/5/10
N/AN/AN/ANo Significant Meetings
Murray M. Lumpkin, M.D., Deputy Commissioner for International Programs2/2/10Rockville, MDN/AVincent Ahonkhai (Bill & Melinda Gates Foundation)International Issues
David Dorsey, J.D., Acting Deputy Commissioner for Policy, Planning, and Budget2/1/10-
2/5/10
N/AN/AN/ANo Significant Meetings
Michael R. Taylor, J.D., Deputy Commissioner for Foods, Office of Foods2/1/10-
2/5/10
N/AN/AN/ANo Significant Meetings
Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research2/1/10Washington, DCDavid Jacobson-Kram John Wagner (Merck); David Savello (Xenoport); Christopher Lipinski (Melior Discovery)ACDRS Session 2  Learning Trials:  From Discovery to First in Humans
Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research2/2/10Bethesda, MDIssam Zineh, Allen Rudman, Robert Becker, Lawrence Lesko, Sue-Jane WangPeter Shaw (Merck & Co., Inc.); Ronald Salerno (Biologics Consulting Group, Inc.); Linda Surh (GlaxoSmithKline)5th Workshop in a Series on Pharmacogenomics:  Generating and Weighing Evidence in Drug Development and Regulatory Decision Making
Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research2/4/10Bethesda, MDN/AN/APrinciples of Clinical Pharmacology
Michael Chappell, Acting Associate Commissioner for Regulatory Affairs2/1/10-
2/5/10
N/AN/AN/ANo Significant Meetings
Karen Midthun, M.D., Acting Director, Center for Biologics Evaluation and Research2/1/10-
2/5/10
N/AN/AN/ANo Significant Meetings
Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health2/2/10Silver Spring, MDJonathan Sackner-Bernstein, Markham Luke, Anthony Watson, Patricia Beaston, Charles Zimiliki, Alberto Gutierrez, Arleen Pinkos, Courtney Harper, Catherine NorcioDarlene Deecher, Bob Goldstein, Campbell Hutton, Aaron Kowalski, Cynthia Rice, Larry Soler, Roy Beck, John Lum, Phil Phillips (Juvenile Diabetes Research Foundation)Medical Devices
Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health2/4/10Silver Spring, MDDonna-Bea Tillman, Jonathan Sackner-Bernstein, Catherine NorcioMark Leahey (Medical Device Manufacturers Association)Medical Devices
Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health2/4/10Silver Spring, MDSteve Silverman, Catherine Norcio, Jonathan Sackner-Bernstein, Maggie DietrichDeepak Shenoy, Navjot Singh, Richard Phillips, Kety George (McKinsey & Company, Inc.)Medical Devices
Stephen Sundlof, D.V.M., Ph.D., Director, Center for Food Safety and Applied Nutrition2/1/10-
2/5/10
N/AN/AN/ANo Significant Meetings 
Bernadette Dunham, D.V.M., Ph.D., Director, Center for Veterinary Medicine2/1/10-
2/5/10
N/AN/AN/ANo Significant Meetings
William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research2/2/10-
2/4/10
Washington, DCN/AN/A35th Annual Winter Toxicological Forum
Ralph Tyler, J.D., Chief Counsel2/1/10-
2/5/10
N/AN/AN/ANo Significant Meetings 
Lawrence Deyton, M.D., M.P.H., Director, Center for Tobacco Products2/1/10-
2/5/10
N/AN/AN/ANo Significant Meetings